[Pharmacological and clinical profile of acotiamide hydrochloride hydrate (Acofide(®) Tablets 100 mg), a novel therapeutic agent for functional dyspepsia (FD)].

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Nihon yakurigaku zasshi. Folia pharmacologica Japonica

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 24531902
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Functional dyspepsia—symptoms, definitions and validity of the Rome III criteria

  2013cited by this paper
• High frequency of overlap between functional dyspepsia and overactive bladder

  2012cited by this paper
• Acotiamide, a new orally active acetylcholinesterase inhibitor, stimulates gastrointestinal motor activity in conscious dogs

  2012cited by this paper
• Large‐scale randomized clinical study on functional dyspepsia treatment with mosapride or teprenone: Japan Mosapride Mega‐Study (JMMS)

  2012cited by this paper
• Classification of functional dyspepsia based on concomitant bowel symptoms

  2012cited by this paper
• Acotiamide hydrochloride (Z-338) enhances gastric motility and emptying by inhibiting acetylcholinesterase activity in rats.

  2011cited by this paper
• A Long-Term Study of Acotiamide in Patients with Functional Dyspepsia: Results from an Open-Label Phase III Trial in Japan on Efficacy, Safety and Pattern of Administration

  2011cited by this paper
• A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia

  2011cited by this paper
• Acotiamide Hydrochloride (Z-338), a New Selective Acetylcholinesterase Inhibitor, Enhances Gastric Motility without Prolonging QT Interval in Dogs: Comparison with Cisapride, Itopride, and Mosapride

  2011cited by this paper
• Clinical characteristics of Japanese dyspeptic patients: is the Rome III classification applicable?

  2010cited by this paper
• Acotiamide hydrochloride (Z‐338), a novel prokinetic agent, restores delayed gastric emptying and feeding inhibition induced by restraint stress in rats

  2008cited by this paper
• Vagal activation by sham feeding improves gastric motility in functional dyspepsia

  2008cited by this paper
• Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials

  2007cited by this paper
• A placebo-controlled trial of itopride in functional dyspepsia.

  2006cited by this paper
• Effects of famotidine, mosapride and tandospirone for treatment of functional dyspepsia

  2005cited by this paper
• Relationship between gastrointestinal and extra-gastrointestinal symptoms and delayed gastric emptying in functional dyspeptic patients.

  2005cited by this paper
• Restraint stress delays solid gastric emptying via a central CRF and peripheral sympathetic neuron in rats.

  2005cited by this paper
• Gastric Emptying and Intragastric Distribution of a Solid Meal in Functional Dyspepsia: Influence of Gender and Anxiety

  2004cited by this paper
• Functional Dyspepsia: Motor Abnormalities, Sensory Dysfunction, and Therapeutic Options

  2004cited by this paper
• Neuroendocrine pharmacology of stress.

  2003cited by this paper
• Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients

  2002cited by this paper
• Dose finding study of mosapride in functional dyspepsia: a placebo‐controlled, randomized study

  2002cited by this paper
• Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia?

  2001cited by this paper
• Treatment of Non-Ulcer Dyspepsia: a Meta-Analysis of Placebo-Controlled Prospective Studies

  2001cited by this paper
• Real‐time ultrasonographic assessment of antroduodenal motility after ingestion of solid and liquid meals by patients with functional dyspepsia

  2000cited by this paper
• The functional gastrointestinal disorders and the Rome III process.

  1999cited by this paper
• Differential effects of clonidine and dexmedetomidine on gastric emptying and gastrointestinal transit in the rat.

  1997cited by this paper
• Vagal control of nitric oxide and vasoactive intestinal polypeptide release in the regulation of gastric relaxation in rat.

  1995cited by this paper
• Low vagal activity as mediating mechanism for the relationship between personality factors and gastric symptoms in functional dyspepsia.

  1994cited by this paper
• Low vagal tone and antral dysmotility in patients with functional dyspepsia.

  1993cited by this paper
• A novel water-soluble dopamine-2 antagonist with anticholinesterase activity in gastrointestinal motor activity. Comparison with domperidone and neostigmine.

  1990cited by this paper
• Gastric emptying in normal subjects and patients with peptic ulcer

  1979cited by this paper
• Diurnal changes in gastric motor activity in conscious dogs

  1977cited by this paper

• A double-blind placebo controlled study of acotiamide hydrochloride for efficacy on gastrointestinal motility of patients with functional dyspepsia

  2017cites this paper